Pathology in dogs with experimental canine H3N2 influenza virus infection

Avian-lineage H3N2 canine influenza virus (CIV)-associated respiratory disease, which can be fatal, emerged in South Korean dogs in 2007. We show here that dogs experimentally infected with CIV only developed respiratory tract diseases, as no extrapulmonary lesions and virus antigens were detected. This differs from the multiorgan diseases that avian influenza H5N1 induces in small experimental animals. However, the CIV-infected dogs developed a distinctively severe, long-persistent bronchointerstitial pneumonia, which differs from the acute but short-term bronchopneumonia that human (H1N1 and H3N2) influenza cause in rodents and ferrets. Histopathology and in situ TUNEL assays revealed that the neutrophils infiltrating the lesions were undergoing apoptosis, which probably reflects the attempts by the body to maintain appropriate numbers of neutrophils for defense against secondary bacterial infections. Our observations suggest that neutrophils along with the related chemoattractant cytokines (TNF-α, IL-1 and IL-8, etc.) may play a key role in the pathogenesis of H3N2 CIV in dogs.     

H3N2亚型犬流感病毒的分离鉴定

为了解广州地区犬流感的流行情况,本研究采集107份犬鼻咽拭子样品和58份血清样品,SPF鸡胚分离病毒并进行抗体检测。结果显示:分离获得3株H3N2亚型犬流感病毒。分离株的EID50为10-2.42/0.1 mL～10-3.5/0.1 mL;MDT为177.6 h～192 h;对乙醚、氯仿、酸和温度均敏感;对血凝素为热不稳定型;能够凝集公鸡、豚鼠、猪和牛的红细胞。     

广东1株H3N2亚型犬流感病毒的分离与鉴定

本试验采集一只具有流感临床症状的病犬鼻咽拭子经常规处理后接种SPF鸡胚,分离到一株流感病毒,并对其进行鉴定及生物学特性研究。结果表明,该毒株对1%鸡红细胞的血凝价为26,能被H3亚型流感病毒阳性血清中和,与H1、H5、H7、H9亚型阳性血清和阴性血清无交叉反应。序列分析显示,该毒株的HA和NA基因核苷酸序列分别与犬流感病毒(CIV)H3和N2亚型的病毒株同源性最高。确定该毒株为H3N2亚型CIV,并将其命名为A/canine/Guangdong/01/2011。     

Seroprevalence of canine influenza virus (H3N8) in Iditarod racing sled dogs

We conducted a cross-sectional convenience sampling study of dogs racing in the 2010 Iditarod to determine the seroprevalence of canine influenza virus (CIV) in the sled dog population. Questionnaires were completed detailing medical and CIV vaccination history, kennel size and location, travel history, and social interactions for each team. A total of 399 dogs were tested for CIV antibodies by hemagglutination inhibition assay. None of these, including 39 samples from dogs reported as CIV vaccinated, were seropositive for CIV antibodies. All of the vaccinated dogs were also negative on virus microneutralization assay. Risk factors for CIV seropositivity could not be determined due to a lack of positive samples. This is the first published study investigating the prevalence of CIV in sled dogs and additional studies are warranted to assess CIV infection among racing sled dogs and to evaluate the ecology of CIV and the vaccine efficacy in this population of dogs.     

Seroprevalence and risk factors for canine H3N8 influenza virus exposure in household dogs in Colorado

Background: Since 2004, canine influenza virus (CIV) has spread throughout the United States. While studies suggest that CIV is commonly detected in shelter dogs, little is known about its prevalence in household dogs. Objectives: To evaluate the seroprevalence of CIV in pet dogs presented for care in a veterinary hospital in Colorado and to investigate risk factors that might predispose these dogs to CIV infection. Animals: One hundred and forty dogs presenting to the Community Practice service, 110 dogs seen at other clinical services at Colorado State University's Veterinary Teaching Hospital in 2009, and samples from 75 dogs seen before 2004. Methods: In this prospective study, samples were tested with hemagglutination inhibition assays, using 3 CIV isolates. To identify risk factors for CIV infection, 140 owners completed questionnaires at time of sampling. Results: CIV seroprevalence was 2.9% (4/140) for dogs seen by the Community Practice service and 4.5% (5/110) for dogs seen by other hospital services (P= .48). All sera collected before 2004 tested negative for CIV. No differences were seen in antibody titers to the 3 CIV isolates tested. Data from the questionnaires indicated an association between CIV seropositivity and canine daycare visits (P < .001). Conclusion and Clinical Importance: CIV seropositivity in household dogs in Colorado is low, although it has increased since 2004. Antibody titers to the 3 CIV isolates were comparable, suggesting that measurable antigenic drift has not yet occurred. Finally, dogs boarded in kennels or attending daycare might be at an increased risk of CIV infection.     

广东1株H3N2亚型犬流感病毒全基因组遗传进化分析

本试验对1株犬源H3N2亚型流感病毒(A/Canine/Guangdong/10/2014)进行了遗传进化分析。结果显示,本毒株8个基因片段与在中国和泰国分离的H3N2亚型犬流感的关系最近,与当前亚洲分离的毒株高度相似(99%)。基因亚型分析显示8个基因片段和目前流行的H3N2CIVs有相同的基因型(K,G,E,3B,F,2D,F,1E)。本毒株为低致病性的禽源H3N2亚型犬流感,从而证实了禽源犬流感亚型在中国的存在,对流感病毒实施广泛的血清学和流行病学检测,以及对该病的防控具有重要意义。     

H3N2犬流感病毒M1蛋白的原核表达及鉴定

为制备犬流感病毒(H3N2) M1蛋白纯品,针对M1基因序列设计引物,用聚合酶链式反应(PCR)扩增目的基因片段,扩增产物克隆至表达载体pET-SUMO中并转化至宿主菌BL21(DE3),诱导表达目的蛋白,探索纯化工艺,制备目的蛋白,并用Western blot检测纯化的M1目的蛋白。通过PCR成功扩增出大小为771 bp的M1基因,成功构建p ET-SUMO-M1表达载体,表达的融合蛋白相对分子量为41 kD,主要以可溶形式表达,纯化后获得蛋白纯品,Western blot检测显示用M1蛋白(28 k D)免疫小鼠制备的多抗能与制备的蛋白纯品发生特异性反应,从而证明蛋白纯品为M1目的蛋白。试验制备出的M1蛋白纯品可为进一步制备通用型抗犬流感病毒抗体提供纯品抗原。     

Identification and characterization of H2N3 avian influenza virus from backyard poultry and comparison with novel H2N3 swine influenza virus

In early 2007, H2N3 influenza virus was isolated from a duck and a chicken in two separate poultry flocks in Ohio. Since the same subtype influenza virus with hemagglutinin (H) and neuraminidase (N) genes of avian lineage was also identified in a swine herd in Missouri in 2006, the objective of this study was to characterize and compare the genetic, antigenic, and biologic properties of the avian and swine isolates. Avian isolates were low pathogenic by in vivo chicken pathogenicity testing. Sequencing and phylogenetic analyses revealed that all genes of the avian isolates were comprised of avian lineages, whereas the swine isolates contained contemporary swine internal gene segments, demonstrating that the avian H2N3 viruses were not directly derived from the swine virus. Sequence comparisons for the H and N genes demonstrated that the avian isolates were similar but not identical to the swine isolates. Accordingly, the avian and swine isolates were also antigenically related as determined by hemagglutination-inhibition (HI) and virus neutralization assays, suggesting that both avian and swine isolates originated from the same group of H2N3 avian influenza viruses. Although serological surveys using the HI assay on poultry flocks and swine herds in Ohio did not reveal further spread of H2 virus from the index flocks, surveillance is important to ensure the virus is not reintroduced to domestic swine or poultry. Contemporary H2N3 avian influenza viruses appear to be easily adaptable to unnatural hosts such as poultry and swine, raising concern regarding the potential for interspecies transmission of avian viruses to humans.     

A serological survey of canine H3N2, pandemic H1N1/09 and human seasonal H3N2 influenza viruses in dogs in China

Influenza viruses have been isolated from dogs in China; however, the extent of influenza infection among dogs is not yet clear. Here, we examined the seroprevalence of avian-origin canine H3N2, pandemic H1N1/09 and human seasonal H3N2 influenza viruses in pet dogs in China during January 2012 to June 2013. The seropositivity rate of canine H3N2, H1N1/09 and human H3N2 were 3.5%, 1.5%, and 1.2%, respectively. Dogs aged 2–5 years were most commonly seropositive to canine H3N2 virus. It is worth noting that two serum samples were positive against both canine H3N2 and H1N1/09 viruses, suggesting the possibility of coinfection with both viruses. Our findings emphasize the necessity for continued surveillance of influenza viruses in dogs in China.     

H3N2亚型犬流感病毒HA1基因的原核表达及抗原性分析

为原核表达H3N2亚型犬流感病毒(CIV)HA1蛋白,本研究利用特异性引物扩增CIV H3分离株的HA1基因,将其克隆到pMD18-T载体后进行序列测定。再将其亚克隆于pET-32a(+)中构建重组表达质粒pET-HA1。将该质粒转化于大肠杆菌BL21(DE3)中,经IPTG诱导,SDS-PAGE电泳分析,表达的重组蛋白约为58 ku。纯化的HA1蛋白经western blot和Dot-ELISA鉴定表明,表达的重组HA1蛋白可以与H3N2亚型CIV阳性血清发生特异性反应。     

H3N2亚型犬流感病毒血凝及血凝抑制试验的研究

为优化H3N2亚型犬流感病毒(CIV)的血凝抑制(HI)试验方法,本研究应用不同种类红细胞进行CIV的血凝(HA)试验,应用不同种类红细胞和不同血清处理方法进行CIV的HI试验,评价其对HA和HI试验的影响。结果表明,H3N2亚型CIV对鸡和犬红细胞的凝集性最好,对小鼠、猪和牛红细胞的凝集性较差。HI试验应用鸡红细胞悬液效果最好,受体破坏酶(RDE)和高碘酸钾处理可以有效去除犬血清中非特异血凝抑制素,但高碘酸钾对血清特异性抗体有损耗。本研究筛选出H3N2亚型CIV HI试验的最佳方法,为犬流感的血清学诊断提供技术支持。     

H3N2亚型犬流感病毒头部缺失血凝素蛋白的真核表达及抗原性研究

为获得一种针对不同亚型流感病毒的共同保护性抗原,本研究以H3N2亚型犬流感病毒(canine influenza virus, CIV)的主要抗原蛋白血凝素(HA)为靶标,以四甘氨酸接头肽替换HA头部结构域,将免疫反应定向至更保守的HA茎部区,同时在HA茎部添加T4折叠三聚体以保护蛋白天然构象,通过杆状病毒表达系统表达头部缺失HA蛋白,并验证其抗原性。结果表明,利用昆虫细胞表达的头部缺失,HA蛋白单一性较好,分子量为47 ku,与CIV全病毒血清抗体可发生特异性结合反应,且头部去除区HA蛋白血清抗体可抑制H1N1和H3N2亚型流感病毒感染所致的细胞病变效应,中和效价分别为1∶160和1∶320。研究结果为制备针对不同亚型流感病毒(如H1N1和H3N2)的广谱疫苗提供了可能。     

Serological evidence of H3N8 canine influenza-like virus circulation in USA dogs prior to 2004

H3N8 canine influenza virus (H3N8 CIV) was first reported as a novel canine respiratory pathogen in racing greyhounds and shelter dogs in the U.S.A. in 2004. Phylogenetic analyses determined that this host-adapted pathogen originated from interspecies transmission of an equine influenza virus (EIV), but it is unknown when the transmission occurred prior to discovery in 2004. The objective of this study was to determine if racing greyhound and shelter dog sera collected from 1984 to 2004 had serological evidence of exposure to H3N8 CIV or EIV. Archived sera from 702 racing greyhounds and 1568 shelter dogs were tested for H3 antibodies to the original 2004 CIV isolate, as well as EIV isolates from 1991 to 1999. None of the racing greyhounds from 1984 and 1985 had detectable H3 antibodies. One of the shelter dogs, which entered a north Florida shelter in 2004, was seropositive. For racing greyhounds sampled from 1999 to 2004, 133/520 (26%) dogs had antibodies to both CIV and EIV H3 proteins. The annual seroprevalence was 27% in 1999, 28% in 2000, 10% in 2001, 1% in 2002, 41% in 2003, and 28% in 2004. The odds of H3 seropositivity were greater among dogs that raced > or =6 months, raced on > or =2 tracks, and raced in 1998, 2002, and 2003. Many of the seropositive dogs raced at tracks that were involved in 'kennel cough' epidemics in 1998-1999 and 2002-2003. Based on serological evidence, a H3N8 canine influenza-like virus was circulating in racing greyhounds in the U.S.A. as early as 1999.     

Reassortant H1N1 influenza virus vaccines protect pigs against pandemic H1N1 influenza virus and H1N2 swine influenza virus challenge

Influenza A (H1N1) virus has caused human influenza outbreaks in a worldwide pandemic since April 2009. Pigs have been found to be susceptible to this influenza virus under experimental and natural conditions, raising concern about their potential role in the pandemic spread of the virus. In this study, we generated a high-growth reassortant virus (SC/PR8) that contains the hemagglutinin (HA) and neuraminidase (NA) genes from a novel H1N1 isolate, A/Sichuan/1/2009 (SC/09), and six internal genes from A/Puerto Rico/8/34 (PR8) virus, by genetic reassortment. The immunogenicity and protective efficacy of this reassortant virus were evaluated at different doses in a challenge model using a homologous SC/09 or heterologous A/Swine/Guangdong/1/06(H1N2) virus (GD/06). Two doses of SC/PR8 virus vaccine elicited high-titer serum hemagglutination inhibiting (HI) antibodies specific for the 2009 H1N1 virus and conferred complete protection against challenge with either SC/09 or GD/06 virus, with reduced lung lesions and viral shedding in vaccine-inoculated animals compared with non-vaccinated control animals. These results indicated for the first time that a high-growth SC/PR8 reassortant H1N1 virus exhibits properties that are desirable to be a promising vaccine candidate for use in swine in the event of a pandemic H1N1 influenza.     

No evidence of horizontal infection in horses kept in close contact with dogs experimentally infected with canine influenza A virus (H3N8)

Background

Since equine influenza A virus (H3N8) was transmitted to dogs in the United States in 2004, the causative virus, which is called canine influenza A virus (CIV), has become widespread in dogs. To date, it has remained unclear whether or not CIV-infected dogs could transmit CIV to horses. To address this, we tested whether or not close contact between horses and dogs experimentally infected with CIV would result in its interspecies transmission.

Methods

Three pairs of animals consisting of a dog inoculated with CIV (10^8.3 egg infectious dose₅₀/dog) and a healthy horse were kept together in individual stalls for 15 consecutive days. During the study, all the dogs and horses were clinically observed. Virus titres in nasal swab extracts and serological responses were also evaluated. In addition, all the animals were subjected to a gross pathological examination after euthanasia.

Results

All three dogs inoculated with CIV exhibited clinical signs including, pyrexia, cough, nasal discharge, virus shedding and seroconversion. Gross pathology revealed lung consolidations in all the dogs, and Streptococcus equi subsp. zooepidemicus was isolated from the lesions. Meanwhile, none of the paired horses showed any clinical signs, virus shedding or seroconversion. Moreover, gross pathology revealed no lesions in the respiratory tracts including the lungs of the horses.

Conclusions

These findings may indicate that a single dog infected with CIV is not sufficient to constitute a source of CIV infection in horses.     

Seroprevalence of antibodies to canine influenza virus in dogs in Ontario

A cross-sectional study evaluating the seroprevalence of antibodies to canine influenza virus in dogs in Ontario was performed. The prevalence was 0.4% (1/225), and the only seropositive dog was a greyhound that originated in Florida.     

一株H9N2亚型禽流感病毒全基因组分析

为了研究H9N2亚型AIV A/Chicken/Guangdong/333/2008的全基因组序列变异情况,试验利用RT-PCR方法扩增出该病毒的8个基因序列,并应用DNAStar和MEGA4.0软件分析所得基因序列。结果表明:该病毒HA基因的第226位氨基酸由Q(Gln)变为了L(Leu),其NP基因与Viet Nam/1203/2004(H5N1)的NP基因同源率最高。说明该病毒已具备了感染哺乳动物的分子特征,并可能在遗传演化过程中突变为高致病性的禽流感病毒(AIV)。     

H3N2亚型犬流感病毒重组HA1蛋白间接ELISA检测方法的建立

为建立一种H3N2亚型犬流感病-毒(CIV)血清学检测方法,本研究利用CIV重组HA1蛋白作为检测抗原,建立H3N2亚型CIV抗体的间接ELISA检测方法,并优化反应条件.通过检测阴性血清样本30份确定其临界值为0.228.该方法与抗猪流感病毒H1N1、H1N2、H6N6、H9N2的阳性血清和犬瘟热病、犬细小病、犬副流感的阳性血清均无交叉反应.变异系数在1.01％～7.52％之间,具有较好的重复性.通过对150份临床样品进行检测并与血凝抑制试验检测结果比较,总符合率为98.6％.本研究为CIV流行病学调查提供了一种快速、方便、敏感的抗体检测方法.